(PDF) miR‑205‑5p Downregulation Decreases Gemcitabine

miR‑205‑5p Downregulation Decreases Gemcitabine Sensitivity of Breast Cancer Cells via ERp29 Upregulation

Experimental and Therapeutic Medicine - Greece

doi 10.3892/etm.2019.7962

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

August 30, 2019

Authors

Publisher

Spandidos Publications

Related search

miR-218-5p Restores Sensitivity to Gemcitabine Through PRKCE/MDR1 Axis in Gallbladder Cancer

Cell Death and Disease

Molecular Neuroscience

Cancer Research

English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology

Cancer Research

English

ERp29 Downregulation Enhances Lung Adenocarcinoma Cell Chemosensitivity to Gemcitabine by Upregulating HSP27 Phosphorylation

Experimental and Therapeutic Medicine

Cancer Research

English

Downregulation of miR-194-5p Induces Paclitaxel Resistance in Ovarian Cancer Cells by Altering MDM2 Expression

English

Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells

OncoTargets and Therapy

English

NT21MP Negatively Regulates Paclitaxel-Resistant Cells by Targeting miR‑155‑3p and miR‑155-5p via the CXCR4 Pathway in Breast Cancer

International Journal of Oncology

Cancer Research

English

Mechanical Compression Induces VEGFA Overexpression in Breast Cancer via DNMT3A-dependent miR-9 Downregulation

Cell Death and Disease

Molecular Neuroscience

Cancer Research

English

Overexpression of Circulating MiR-30b-5p Identifies Advanced Breast Cancer

Journal of Translational Medicine

Molecular Biology

English

Downregulation of miR-216a-5p by Long Noncoding RNA PVT1 Suppresses Colorectal Cancer Progression via Modulation of YBX1 Expression

Cancer Management and Research

English